Skip to main content
ICCC
NASDAQ Life Sciences

ImmuCell Swings to $953K Profit as Q3 Revenue Jumps 46% to $8.0M

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$10.22
Mkt Cap
$92.82M
52W Low
$4.52
52W High
$12.1
52W Position info
126% above low
Off High info
16% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ICCC has more than doubled off its 52-week low of $4.52.

Summary

ImmuCell posted Q3 revenue of $8.0M, up 46% year over year, and net income of $953K — a $1.1M improvement from a year ago. Gross margin came in at 44.2%, up 130 basis points, helped by higher pricing and better manufacturing execution. The top line got an assist from an easier comparison: last year's Q3 was dented by distributor destocking, though out-the-door volume still grew 18%, so the underlying demand is real. Two balance-sheet items matter here: the company terminated its at-the-market offering, removing a dilution overhang, and it expects to sign a new $3M credit line in Q4 2026. This follows the October 12 preliminary sales release and the October 13 8-K that attached it — the new information is the profit, margin and financing detail. Watch whether the $3M credit line actually gets signed in Q4, and whether the capacity expansion and colostrum-sourcing spend start showing up in margins.

At the time of this announcement, ICCC was trading at $10.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $92.8M. The 52-week trading range was $4.52 to $12.10. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

ICCC - Latest Insights

ICCC
Nov 12, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.22
Real-time Price: $10.50 info
Change: +$0.280 (+3%) info
Market Cap: $92.82M info
ICCC
Oct 12, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.00
Real-time Price: $10.50 info
Change: +$0.500 (+5%) info
Market Cap: $92.82M info
ICCC
Aug 13, 2026, 4:14 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $10.90
Real-time Price: $10.50 info
Change: -$0.400 (-4%) info
Market Cap: $92.82M info
ICCC
Aug 13, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.90
Real-time Price: $10.50 info
Change: -$0.400 (-4%) info
Market Cap: $92.82M info
ICCC
Jul 09, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $11.46
Real-time Price: $10.50 info
Change: -$0.955 (-8%) info
Market Cap: $92.82M info